We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Achieve Life Sciences Inc | NASDAQ:ACHV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 4.16% | 5.01 | 4.35 | 5.03 | 5.08 | 4.84 | 4.84 | 208,586 | 01:00:00 |
December 30, 2022
By EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7010
Re: Achieve Life Sciences, Inc.
Registration Statement on Form S-3 (File No. 333-269059)
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-3 (File No. 333-269059) filed by Achieve Life Sciences, Inc. on December 29, 2022 (the Registration Statement). Pursuant to Rule 473(c) of the Securities Act of 1933 (the Act), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the cover page of the Registration Statement.
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
If you have any questions or comments in connection with this delaying amendment, please contact Amanda Rose (206-389-4553) of Fenwick & West LLP.
Sincerely,
/s/ John Bencich |
John Bencich |
Chief Executive Officer |
1 Year Achieve Life Sciences Chart |
1 Month Achieve Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions